STOCK TITAN

Lixte Biotechnology Holdings (LIXT) Debt by Year

LIXT NASDAQ

Lixte Biotechnology Holdings, Inc. held $5.1M in cash and equivalents at the end of fiscal year 2025, and no long-term debt figure is on record for that period. The table below carries 15 fiscal years, from 2011 to 2025, and the quarters Lixte Biotechnology Holdings, Inc. has filed alongside them.

FY2025 annual
Long-Term Debt N/A
Cash & Equivalents $5.1M

Ticker history: LIXT became NMAD (Nomad Power Solutions, Inc.) on .

Source SEC Filings (10-K/10-Q) Latest period Q1 FY2026, ended Mar 31, 2026 Reported Currency USD

Annual figures, oldest first. Point at a bar to read its period.

LIXT Debt & Cash by Fiscal Year

Figures are in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.

MetricFY2510-KFY2410-KFY2310-KFY2210-KFY2110-KFY2010-KFY1910-KFY1810-KFY1710-KFY1610-KFY1510-KFY1410-KFY1310-KFY1210-KFY1110-K
Long-Term DebtN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Cash & Equivalents$5.1M+391.5%$1.0M-75.3%$4.2M-21.5%$5.4M+11.0%$4.8M-4.8%$5.1M+95.1%$2.6M-39.2%$4.3M+227.2%$1.3M+553.1%$200K+690.8%$25K-43.1%$44K-90.7%$475K-71.3%$1.7M+11473.5%$14K

LIXT Debt & Cash by Quarter

Figures are in USD. Each change compares the quarter with the same quarter a year earlier.

MetricQ1'2610-QQ4'2510-KQ3'2510-QQ2'2510-QQ1'2510-QQ4'2410-KQ3'2410-QQ2'2410-QQ1'2410-QQ4'2310-KQ3'2310-QQ2'2310-Q
Long-Term DebtN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Cash & Equivalents$3.3M+134.8%$5.1M+391.5%$2.9M+76.3%$887K-65.8%$1.4M-59.4%$1.0M-75.3%$1.6M-67.9%$2.6M-10.9%$3.4M-16.5%$4.2M-21.5%$5.1M-22.2%$2.9M-62.3%

What long-term debt means

Long-term debt is borrowing that falls due more than a year out, and the cash line beside it is what the company held on the same balance sheet date.

More Lixte Biotechnology Holdings, Inc. financials

Frequently Asked Questions

Lixte Biotechnology Holdings, Inc. held $5.1M in cash and equivalents at the end of fiscal year 2025, and no long-term debt figure is on record for that period.

Long-term debt is borrowing that falls due more than a year out, and the cash line beside it is what the company held on the same balance sheet date. This page lists what Lixte Biotechnology Holdings, Inc. (LIXT) reported on that line in every period on record.